ReviewBiochemical pharmacology2021

Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).

Yusen Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.